Clinical Trials
2 trialsNCT05234437 2023-04-19
A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma
QBiotics Group Limited
Phase 2 Terminated
NCT04834973 2023-04-18
A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma
QBiotics Group Limited
Phase 1/2 Terminated